We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+11.03%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$10.6B
AUM Growth
+$1.17B
Cap. Flow
+$3.01B
Cap. Flow %
28.27%
Top 10 Hldgs %
22.3%
Holding
850
New
52
Increased
273
Reduced
342
Closed
48

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$96.9M
2
MRK icon
Merck
MRK
+$73.5M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$57.1M
4
ILMN icon
Illumina
ILMN
+$40.4M
5
TMO icon
Thermo Fisher Scientific
TMO
+$34.2M

Sector Composition

Rank Sector Weight
1 Healthcare 35.77%
2 Technology 20.35%
3 Consumer Discretionary 9.49%
4 Communication Services 7.69%
5 Financials 7.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CMI icon
151
Cummins
CMI
$88.5B
$17M 0.16%
80,492
+45,182
+128% +$9M
ZGNX
152
DELISTED
Zogenix, Inc.
ZGNX
$17M 0.16%
947,329
HUM icon
153
Humana
HUM
$46.7B
$17M 0.16%
40,994
-1,811
-4% -$728K
SLAB icon
154
Silicon Laboratories
SLAB
$7.17B
$16.5M 0.16%
168,967
-2,513
-1% -$253K
KURA icon
155
Kura Oncology
KURA
$826M
$16.5M 0.16%
539,196
+299,492
+125% +$6.61M
CI icon
156
Cigna
CI
$79.6B
$16.5M 0.15%
97,151
+32,202
+50% +$5.67M
IBM icon
157
IBM
IBM
$214B
$16.4M 0.15%
140,980
+3,183
+2% +$375K
BIDU icon
158
Baidu
BIDU
$35.6B
$16.2M 0.15%
128,312
+88,284
+221% +$10.9M
AXP icon
159
American Express
AXP
$227B
$15.8M 0.15%
157,905
-85,314
-35% -$8.39M
OKTA icon
160
Okta
OKTA
$23.7B
$15.8M 0.15%
73,910
+66,873
+950% +$13.9M
HRC
161
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$15.7M 0.15%
188,428
+43,669
+30% +$4.27M
ELV icon
162
Elevance Health
ELV
$83.7B
$15.6M 0.15%
58,139
+18,270
+46% +$4.92M
CPB icon
163
Campbell Soup
CPB
$6.8B
$15.3M 0.14%
315,636
+61,418
+24% +$3.03M
RETA
164
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$15.3M 0.14%
156,584
MCO icon
165
Moody's
MCO
$83.9B
$15.2M 0.14%
52,542
+35,564
+209% +$10.2M
LULU icon
166
lululemon athletica
LULU
$13.7B
$15.1M 0.14%
45,943
+10,924
+31% +$3.65M
QRVO icon
167
Qorvo
QRVO
$8.09B
$15.1M 0.14%
116,949
+111,035
+1,877% +$13.8M
BLD
168
DELISTED
TopBuild
BLD
$15M 0.14%
88,131
+6,653
+8% +$955K
CHD icon
169
Church & Dwight Co
CHD
$23.7B
$15M 0.14%
160,521
+8,855
+6% +$804K
NBIX icon
170
Neurocrine Biosciences
NBIX
$18.4B
$15M 0.14%
156,282
NOW icon
171
ServiceNow
NOW
$114B
$15M 0.14%
154,825
+81,575
+111% +$7.29M
BMCH
172
DELISTED
BMC Stock Holdings, Inc
BMCH
$14.8M 0.14%
+346,601
New +$11.4M
EBAY icon
173
eBay
EBAY
$52.1B
$14.8M 0.14%
284,058
-4,837
-2% -$266K
MGNX icon
174
MacroGenics
MGNX
$245M
$14.7M 0.14%
581,854
+113,421
+24% +$3.1M
UPS icon
175
United Parcel Service
UPS
$89.7B
$14.2M 0.13%
85,292
-2,795
-3% -$407K

Similar funds

Candriam SCA's Q3 2020 Portfolio in Review

As of Q3 2020, Candriam SCA held 850 positions worth $10.6B, up 12% from $9.47B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Candriam SCA deployed $3.01B of net new capital in Q3 2020, opening 52 new positions and adding to 273 existing holdings. Its largest new stake was VIVINT SOLAR, INC.: 840,936 shares worth $35.6M.

By sector, the portfolio is most concentrated in Healthcare at 36% of assets, up from 35% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Apple, an estimated $57.2M trimmed.

  • Candriam SCA's largest Q3 2020 buy was VIVINT SOLAR, INC.: 840,936 shares worth $35.6M.
  • Candriam SCA added most to Amgen in Q3 2020, an estimated $96.9M increase.
  • Candriam SCA's biggest Q3 2020 reduction was Apple, cutting an estimated $57.2M.
  • Candriam SCA fully exited G1 Therapeutics, Inc. Common Stock in Q3 2020, selling an estimated $21.1M.
  • Candriam SCA's ten largest holdings make up 22% of its $10.6B portfolio in Q3 2020.
  • Candriam SCA opened 52 new positions and closed 48 in Q3 2020.
  • Candriam SCA's portfolio value rose 12% quarter-over-quarter to $10.6B.

Based on Candriam SCA's 13F filing for Q3 2020, filed 19 Oct 2020.